Answers are grounded in this paper and cite their sources.
Background This study investigated the protective effects of puerarin, a natural isoflavone compound, on hypertension comorbid with depression (HD) and its potential mechanism involving the JAK2/STAT3 signaling pathway. HD represents a significant clinical challenge characterized by poor prognosis and limited treatment options, underscoring the urgent need for effective interventions. Methods We established an HD model using spontaneously hypertensive rats (SHR) subjected to chronic unpredictable mild stress (CUMS) combined with social isolation. The rats were randomly divided into six groups: WKY control, HD model, positive control (fluoxetine + amlodipine besylate), and low-, medium-, and high-dose puerarin groups. Drugs were administered via intraperitoneal injection for 28 consecutive days. Results Results showed that HD model rats exhibited significantly elevated systolic blood pressure and pronounced depression-like behaviors, including reduced locomotor activity, anhedonia, behavioral despair, and cognitive impairment. Puerarin intervention dose-dependently reduced blood pressure and improved behavioral indicators. Histological analysis revealed that puerarin alleviated hippocampal neuronal damage and increased Nissl body counts. ELISA detection indicated elevated levels of TNF-α, IL-6, and IL-1β in the hippocampal region of model rats, which were significantly suppressed by puerarin. Immunohistochemistry further demonstrated that puerarin effectively inhibited the overexpression of p-JAK2 and p-STAT3 proteins in the hippocampus of the HD model. Serum ELISA further showed that renin, angiotensin II (Ang II), and aldosterone were elevated in HD model rats and were reduced by puerarin treatment, consistent with attenuation of renin–angiotensin–aldosterone system (RAAS) activation. These concurrent changes suggest potential crosstalk between JAK2/STAT3 signaling and RAAS activation. Conclusion In summary, puerarin ameliorates HD-related behavioral manifestations and hippocampal neuronal damage, and this effect is associated with inhibition of JAK2/STAT3 signaling pathway activation, attenuation of RAAS activation, and reduction of hippocampal TNF-α, IL-6, and IL-1β levels, suggesting its potential as a therapeutic candidate for this comorbidity.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: